Can a psoriasis drug help regrow hair? small study tests injections

NCT ID NCT07029204

Ongoing Disease control Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 2 times

Summary

This pilot study tests whether injecting cyclosporine directly into the scalp can safely regrow hair in people with alopecia areata, an autoimmune disease causing patchy hair loss. Twelve adults with mild to moderate hair loss will receive either cyclosporine or saline injections over 12 weeks. The goal is to see if this approach works and is safe, potentially offering a new option with fewer side effects than oral cyclosporine.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cyclosporine
What this could lead to: If it works, this could point toward a new injection treatment for alopecia areata with fewer side effects than oral cyclosporine.
What could go wrong: This is a very early pilot study with only 12 people, so results may not apply broadly. The treatment is still experimental and may not work or could cause side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia areata

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALOPECIA AREATA

Contacts and locations

Locations

University of California, Davis - Dermatology Department

Sacramento, California, 95816, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.